New studies link diabetes drug Ozempic to increased risk of NAION, a rare eye condition causing vision loss. Danish Medicines ...

Denmark's drug regulator has asked the European Medicine Agency's safety committee to evaluate two studies that found a potential link between Novo Nordisk's (NVO) type 2 diabetes drug Ozempic ...

Neither drug is considered as effective as the brand-name weekly injections sold for diabetes and weight loss as Ozempic and Wegovy by Novo Nordisk and Mounjaro and Zepbound by Eli Lilly.

That news was welcome to rival Eli Lilly and Co., which makes weight-loss drugs Zepbound and Mounjaro that compete with Novo Nordisk’s Wegovy and Ozempic. Tomi Kilgore is MarketWatch's deputy ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

COPENHAGEN, Dec 18 (Reuters) - The European Union's drug regulator said it would assess two new Danish studies that link Novo Nordisk's (NOVOb.CO), opens new tab popular diabetes drug Ozempic to a ...

While Lilly and Novo Nordisk have each been approved to treat weight loss, it's important to understand the finer details of their respective medications. Novo's Ozempic is approved by the U.S ...

COPENHAGEN, Dec 16 (Reuters) - Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two Danish studies linking Novo Nordisk's ...

An X post from Elon Musk on Wednesday highlighted Tesla (TSLA) CEO's newfound preference for Eli Lilly's (NYSE:LLY) weight loss therapy Mounjaro over Novo Nordisk's (NVO) rival product Ozempic.

Novo Nordisk CEO Lars Fruergaard Joergensen in December during a presentation of a new production site. The company's latest attempt at a weight loss drug, CagriSema, matched the bar set by a ...